Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
03/2005
03/24/2005WO2004064869A3 Amyloid-binding, metal-chelating agents
03/24/2005WO2004046162A8 Non-steroidal fxr agonists
03/24/2005WO2004039795A3 Amide compounds for the treatment of hyperlipidemia
03/24/2005US20050065339 Amino-alkyl derivatives
03/24/2005US20050065198 Inhibitors of 15-lipoxygenase
03/24/2005US20050065197 Thiazole derivatives with fungicidal activity
03/24/2005US20050065196 Azole compound and medicinal use thereof
03/24/2005US20050065193 Carbamates of 2-heterocyclic-1,2-ethanediols
03/24/2005US20050065189 Thiazole derivatives as cannabinoid receptor modulators
03/24/2005US20050065118 Compound containing 1,3,4-thiadiazole group; anticancer agents; autoimmune disease; antidiabetic agents
03/24/2005US20050065095 Antibacterial agents
03/24/2005US20050065066 Stabilised insulin compositions
03/24/2005US20050064538 assembling oligopeptide intermediates; protecting thioester-modified oligopeptide intermediates from self-ligations or concatemerizations; eliminates self-ligation of bi-functional intermediates
03/24/2005CA2539016A1 Organic compounds
03/24/2005CA2537841A1 Modulators of atp-binding cassette transporters
03/24/2005CA2482232A1 Protease inhibitor conjugates and antibodies useful in immunoassay
03/23/2005EP1515960A1 2-thioxothiazole derivative, method for preparing the same, and pharmaceutical composition containing the same
03/23/2005EP1515944A1 Aspartyl protease inhibitors
03/23/2005EP1515726A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors
03/23/2005EP1347969B1 5- (pyrazol-4-yl)carbonyl]benzazolone as herbicide
03/23/2005EP1098647B1 Compounds and compositions for treating tissue ischemia
03/23/2005CN1599729A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/23/2005CN1599717A Cyclic diamine compounds having fused-ring groups
03/23/2005CN1597673A Paro methylsulfonyl phongl acrylic acid derivative and its preparation method and antiinflammation action
03/23/2005CN1597668A Biamido heterocyclic derivative with antitumour activity and its preparation method and use
03/23/2005CN1193788C Beta 2-adrenergic receptor agonist
03/22/2005US6869975 Linked biaryl compounds
03/22/2005US6869974 Pharmaceutical compounds
03/22/2005US6869967 Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives
03/22/2005US6869953 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
03/22/2005US6869945 Antihistamines; respiratory system disorders; antiinflammatory agents
03/22/2005CA2257772C Bicyclic¬3.1.0|hexanes and related compounds
03/22/2005CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same
03/17/2005WO2005023804A1 Peptidyl heterocyclic ketone derivatives and preparation processes
03/17/2005WO2005023261A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
03/17/2005WO2004110418A3 Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
03/17/2005US20050059810 Dibenzylamine compound and medicinal use thereof
03/17/2005US20050059717 Pramipexole acid addition salts
03/17/2005US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor
03/17/2005US20050059712 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma
03/17/2005US20050059710 Diphenylamino ketone derivatives as MEK inhibitors
03/17/2005US20050059668 Substituted acylpiperazine derivatives
03/17/2005US20050059607 Process for preparing peptidyl heterocyclic ketone derivatives
03/17/2005CA2538135A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
03/16/2005EP1514544A1 Antiallergic
03/16/2005EP1513911A1 Phosphorescent and luminescent conjugated polymers and their use in electroluminescent assemblies
03/16/2005EP1513818A2 Heterocyclic inhibitors of kinases
03/16/2005EP1513802A1 Alpha-sulfonylamino-acetonitriles
03/16/2005EP1513796A2 Phenyloxyalkanoic acid derivatives as hppar activators
03/16/2005EP1049664B1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
03/16/2005EP1043319B1 Novel alkylamino derivatives
03/16/2005CN1596240A Chalcone derivatives and their use to treat diseases
03/16/2005CN1596112A Benzothiazole derivatives
03/16/2005CN1596111A Methods and compositions for ameliorating the undesirable effects of chemotherapy
03/16/2005CN1193024C Process for producing optically active sulfoxide devivative'
03/16/2005CN1193020C Process for preparing amic acid esters
03/16/2005CN1193010C Heterocyclonitrogen heteroethane derivant with antiviral activity
03/15/2005US6867333 Epothilone synthesis building blocks iii and iv: asymmetrically substituted acyloins and acyloin derivatives, methods for their production and methods for the production of epothilones b, d and epothilone derivatives
03/15/2005US6867305 For cancer therapy
03/15/2005US6867304 Chromogens
03/15/2005US6867225 Alpha type human peroxisome proliferator activated receptor agonists; such as 2-methyl-2-(3-methyl-4-(((4-phenoxymethyl-2-(4-trifluoromethylphenyl) -thiazol-5-yl-carbonyl)-amino)-methyl)phenoxy)propionic acid
03/15/2005US6867224 Thiazole or oxazole derivatives such as 5-(4-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl)-indan-2-carboxylic acid
03/15/2005US6867208 Vitronectin receptor antagonists, their preparation and their use
03/10/2005WO2005021536A2 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors
03/10/2005WO2005021523A1 Piperazine substituted compounds used as calcium channel blockers
03/10/2005WO2005021519A2 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases
03/10/2005WO2005021507A1 Azine derivatives, agricultural or horticultural bactericide, and process for producing the same
03/10/2005WO2005021490A2 N-SULFONYL-α-AMINO-ACID DERIVATIVES
03/10/2005WO2005021486A1 Ester derivative and medicinal use thereof
03/10/2005WO2005020990A1 Antibiotic thiazolidines
03/10/2005WO2005020899A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity
03/10/2005WO2004041802A8 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
03/10/2005WO2004041794A8 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines
03/10/2005US20050054819 Such as 1-benzylcyclobutyl (1S)-1-(oxo{[(1R)-1-phenylethyl]amino}acetyl)pentylcarbamate for treatment of osteoporosis
03/10/2005US20050054715 Vinyl phenyl derivatives as glk activators
03/10/2005US20050054698 4-(4Methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3(gsk3)
03/10/2005US20050054685 Pharmaceutical composition
03/10/2005US20050054683 Microbiocides; bacteriocides; oxazolidinone compound
03/10/2005US20050054675 Interferon $g(g) production promoter
03/10/2005US20050054674 Activator of peroxisome proliferator-activated receptor
03/10/2005US20050054626 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
03/10/2005US20050054582 Para-amino benzoic acids as integrin antagonists
03/10/2005CA2537487A1 Piperazine substituted compounds used as calcium channel blockers
03/10/2005CA2537123A1 New compounds
03/10/2005CA2533175A1 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases
03/09/2005EP1512704A1 High refractive index, UV-curable monomers and coating compositions prepared therefrom
03/09/2005EP1512397A1 O-substituted hydroxyaryl derivatives
03/09/2005EP1511724A1 Process for the preparation of thioalkylamine derivatives
03/09/2005EP1123918B1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same
03/09/2005CN1592869A Polymeric material, containing a latent acid
03/09/2005CN1592746A LFA-1 antagonist compounds
03/09/2005CN1592744A Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activity
03/09/2005CN1592735A Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives
03/09/2005CN1590379A New heterocyclic oxime compounds, preparing process and medical composition thereof
03/09/2005CN1590357A Lightfast additive having uv-absorbing moiety and ink composition including the same
03/09/2005CN1192015C Cell adhesion inhibitors
03/08/2005US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents
03/08/2005US6864290 Statine derivatives for the treatment of Alzheimer's disease
03/08/2005US6864270 Iron binding agents
03/08/2005US6863838 Low melting point
1 ... 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 ... 337